The dominant cerebellar ataxias are a clinically and genetically heterogeneous group of disorders that cannot be differentiated reliably from each other on a clinical basis. DNA testing is highly sensitive and specific and provides a definitive diagnosis for an estimated 50-60% of Caucasian patients with findings of dominant cerebellar ataxia. Patient DNA is analyzed to determine the number of CAG trinucleotide repeats located within each allele of the five causative genes; an abnormally large number of CAG repeats is diagnostic for the disease.
Two categories of tests are available:
Estimated Percent of Dominant Cerebellar Ataxias:
Notes:
Indications for testing include:
Code | Name |
---|---|
SCA1A1 | SCA1 ATXN1 Allele 1 |
SCA1A2 | SCA1 ATXN1 Allele 2 |
SCA2A1 | ATXN2 (SCA2), allele 1 |
SCA2A2 | ATXN2 (SCA2), allele 2 |
SCA3A1 | ATXN3 (SCA3), allele 1 |
SCA3A2 | ATXN3 (SCA3), allele 2 |
SCA6A1 | CACNA1A (SCA6), allele 1 |
SCA6A2 | CACNA1A (SCA6), allele 2 |
SCA7A1 | ATXN7 (SCA7), allele 1 |
SCA7A2 | ATXN7 (SCA7), allele 2 |
SCAITP | SCA1 Interpretation |
SCACOM | SCA1 Comment |
SCAPDI | SCA Panel Director |
Polymerase Chain Reaction (PCR)/Capillary Electrophoresis.
The region containing the CAG repeat of the indicated gene for a specific type of spinocerebellar atxia (ATXN1, ATXN2, ATXN3, CACNA1A, ATXN7) was amplified and fragment lengths determined by comparison to molecular weight standards after capillary electrophoresis. This test was developed and its performance characteristics determined by the Department of Laboratory Medicine at the University of Washington.
Normal | Mutable Normal | Intermediate Penetrance | Full Penetrance | |
SCA1 | Less than or equal to 44 repeats depending on the reflex testing | 36-38 repeats | 39-44 repeats, reflex testing required | Greater than or equal to 44 repeats, depending on the reflex testing |
SCA 2 | <32 repeats | 32 repeats | >32 repeats | |
SCA 3 | <45 repeats | >44 repeats | ||
SCA 6 | <19 repeats | 19 repeats | 19 repeats | >19 repeats |
SCA 7 | <19 repeats | 28-33 repeats | 34-36 repeats | >36 repeats |
Acceptable:
Unacceptable: Heparin green top tubes, buccal swab
SPS specimen handling:
For clients outside of UW, please include any relevant clinical history.
If fetal tissue (cultured amniocytes or chorionic villi) was received for prenatal testing, consultation with the laboratory is required. Please notify the Genetics lab about prenatal studies via email at geneticshelp@uw.edu or call 206-598-7021.
UW-MT |
Genetics
Attention: Genetics Lab Tel: 206-598–6429 M–F (7:30 AM–4:00 PM) Tel (EXOME only): 206-543-0459 |
Faculty |
---|
For pricing information, contact Client Support Services 206-520-4600 or 800-713-5198.